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Porins and lipopolysaccharide stimulate platelet activating factor syn-
thesis by human mesangial cells. Porins, a family of hydrophobic
proteins located in the outer membrane of the cell wall of gram-negative
bacteria and Iipopolysaccharide (LPS), were shown to stimulate the
synthesis of platelet activating factor (PAF), a phospholipid mediator of
inflammation and endotoxic shock, by cultured human glomerular
mesangial cells (MC). The synthesis of PAF induced by porins was
rapid (peak at 20 mm) and independent either from contamination by
LPS or from generation of an endotoxin-induced cytokine such as
tumor necrosis factor (TNF) since it was not prevented by cyclohex-
imide, an inhibitor of protein synthesis or anti-TNF blocking antibod-
ies. LPS also stimulated PAF synthesis by MC. However, the kinetic of
PAF synthesis induced by LPS was biphasic with an early and transient
peak at 10 minutes and a second and sustained peak at three to six
hours. This second peak required an intact protein synthesis and was
prevented by anti-TNF antibodies, suggesting the dependency on
LPS-induced synthesis of TNF. Experiments with labeled precursors
demonstrated that in MC, either after stimulation with porins or LPS,
PAF was synthetised via the remodeling pathway that involves acety-
lation of l-0-alkyl-sn-glyceryl-3-phosphorylcholine (2-lyso-PAF) gener-
ated from 1-0-alkyl-2-acyl-sn-glyceryl-3-phosphorylcholine by phos-
pholipase A2 (PLA2) activity. Porins and LPS, indeed, induced PLA2-
dependent mobilization of ['4C]-arachidonic acid that was inhibited by
p-bromodiphenacylbromide (PBDB). PBDB, an inhibitor of PLA2, also
blocked PAF synthesis by preventing the mobilization of 2-lyso-PAF,
the substrate for PAF-specific acetyltransferase. The addition of 2-lyso-
PAF restored PAF synthesis. The activity of acetyl C0A:2-lyso-PAF
acetyltransferase was increased in porin- as well as in LPS-stimulated
MC and, after cell preincubation with [3H]-acetyl CoA, [3H]-acetyl was
incorporated in the newly synthetised PAF. The activation of PAF
synthesis by porins was dependent on extracellular Ca2. Porins by
forming trans-membrane channels determined a sustained influx of
45Ca2 into the cytosol. The inhibitory effect of trifluoperazine, an
inhibitor of Ca2-ca!modulin complexes, on PAF synthesis by porin-
stimulated MC suggested that calmodulin mediated the Ca2-dependent
activation of enzymes involved in PAF synthesis.
Platelet activating factor (PAF), a 1 -0-alkyl-2-acetyl-sn-glyc-
eryl-3-phosphorylcholine, is a mediator of endotoxin-induced
inflammation and shock [1—4]. PAF is synthesized by polymor-
phonuclear neutrophils (PMN), monocytes/macrophages, baso-
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phils, platelets and vascular endothelial cells [5] after appropri-
ate stimulation. Recently, rat and human mesangial cells (MC)
have been found to be able to produce PAF and to be sensitive
to its action [6—10]. It was demonstrated that cultured rat MC
exhibit specific receptors for IgG and the occupancy of Fc
receptors results in endocytosis associated with the generation
of PAF [11]. Therefore, MC seem to behave as macrophages
that synthesized PAF during phagocytosis [12]. PAF may be
synthesized, either via the remodeling pathway, through acety-
lation of 2-lyso-PAF generated from 1-0-alkyl-2-acyl-sn-glyc-
eryl-3-phosphorylcholine by phospholipase A2 (PLA2) activity,
or via the de novo biosynthetic pathway that involves the
synthesis of l-0-alkyl-2-acetyl-sn-glycerol, which is then con-
veiled to PAF by a unique CDP-choline:l-alkyl-2-acetyl-sn-
glycerol cholinephosphotransferase [13]. In human MC phago-
cytosis induces PAF synthesis mainly via the remodeling
pathway [14].
The synthesis of PAF in endotoxin-induced inflammation and
shock may be triggered either by endotoxin itself or by endo-
toxin-induced cytokines. Indeed, TNF, a cytokine primarily
involved in endotoxin-induced inflammation and shock [15],
stimulates PAF synthesis by activating the remodeling pathway
in PMN, macrophages, endothelial and MC [14, 16]. In addi-
tion, endotoxin was found to be able to stimulate PAF synthesis
by cultured rat MC [9]. In human MC, it remains to be
determined whether the synthesis of PAF is directly stimulated
by endotoxin or whether it is related to the autocrine effect of
endotoxin-induced cytokines. Moreover, it is at present un-
known whether other bacterial components can stimulate the
synthesis of PAF by MC.
In the present investigation, we compared the effect of porins
on the biosynthesis of PAF by cultured human MC with that of
bacterial lipopolysaccharide (LPS). Porins are a family of
hydrophobic proteins located in the outer membranes of the
gram-negative bacteria cell-wall that form transmembrane
channels (pores) for passive diffusion of small solutes [17].
Porins may also play a role in bacterial virulence due to their
ability to bind the membrane of nucleated cells and to interfere
with their functions [18].
The results obtained show that porins stimulate the synthesis
of PAF from human MC in a manner distinct from that of LPS.
Porins directly stimulate the MC by a mechanism that involves
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the influx of extracellular Ca2 and the activation of the
enzymes involved in the remodeling pathway. LPS activates a
dual mechanism resulting in an early but transient direct acti-
vation of PAF synthesis, followed by a delayed and sustained
synthesis dependent mainly on an autocrine action of TNF.
The effect of bacterial components on PAF synthesis by MC
may be of significance for the pathogenesis of acute renal injury
occurring during gram-negative sepsis.
Methods
Materials
Human recombinant tumor necrosis factor (TNF) and anti-
human TNF antibodies were a gift of Dr. Baglioni (State
University of New York at Albany, USA); 2 g/ml of anti-
human TNF antibodies were shown to prevent the cytotoxic
activity of 10 ng/ml TNF on SK-MEL 109 melanoma cells
tested using the method described by Ruggiero et al [19]. SDZ
63675 (Sandoz Research Institute, East Hanover, New Jersey,
USA), WEB 2170 (Boehringer Ingelheinike, Mannheim, Ger-
many), and CV 3988 (Takeda Chemical industries, Osaka,
Japan) were used as specific PAF receptor antagonists. Poly-
myxin B, phospholipase A2, lipase Al, bovine serum albumin
(BSA) fraction V (tested for not more than 1 ng endotoxin per
mg), acetyl-coenzyme A (acetyl-CoA), p-bromodiphenacylbro-
mide (PBDB), sphingomyelin and lyso-2-phosphatidylcholine
(lyso-PC), and fluorescein-labeled phalloidin (F-PHD) were
purchased from Sigma Chemical Company (St. Louis, Mis-
souri, USA). PAF and 1-0-octadecyl-2-lyso-glycero-3-phospho-
choline (lyso-PAF), phosphoryicholine (PC) and phosphatid-
ylethanolamine (PE) were from Bachem Feinchemikalien
(Bubendorif, Switzerland). [3Hlacetyl-CoA (2 Ci/mmol), [meth-
yl-3}{]-choline (75 Ci/mmol) and [14C]arachidonic acid (55.5
mCi/mmol) were purchased from Amity, Milano, Italy. 45Ca (30
mCi/mg calcium) was obtained from Amersham (Bucks, United
Kingdom). Collagenase from C. histolyticum was from Boehr-
inger; human factor Viii antiserum was from Nordic Immunol-
ogy (Tilburg, The Netherlands); mouse monoclonal anti-HLA-DR
and anti-leukocyte common antigen (CD45) antibodies were pur-
chased from Beckton-Dickinson (Milano, Italy); anti-smooth mus-
cle cell myosin antibodies were from Immunotech (Marseille,
France); mouse monoclonal anti-cytokeratin antibodies, anti-
collagen type IV antibodies and anti-fibronectin were from
Labometrics (Milano, Italy).
Preparation of porins
A strain of Salmonella typhimurium SH5014, provided by
Nurminen (Central Public Health Laboratory, Helsinki, Fin-
land), was used as the source of porins. Porins extracted by the
method of Nurminen [201 were further purified by means of gel
filtration in the presence of detergent (SDS) [21] to remove LPS
contamination. As previously described [18], the SDS-polyac-
rylamide 12% gel electrophoresis of purified porins showed two
bands with molecular weights of 34 kD and 36 kD in samples
heated for five minutes at 100°C in SDS. LPS contamination in
the final preparations of porins was only 10 pg of LPS, detected
by Limulus assay, per 100 g of porins. In selected experi-
ments, porins were incubated with 5 sg/ml polymyxin B at
room temperature for one hour to neutralize the biological
activity of the traces of contaminating LPS as described by
Blanchard et al [22].
LPS from E. coli (01 ll:B4) was purchased by Sigma Chem-
ical Co., and LPS from Salmonella typhimurium was purchased
from Difco Laboratories (Detroit, Michigan, USA). Stock so-
lutions of LPS were prepared by suspending 10 mg of LPS in 2
ml 20 m EDTA and sonicating until clarified (3 to 5 20-second
bursts at maximum intensity using a W375 sonicator with a No.
419 microtip, Heat Systems-Ultrasonics, Farmingdale, New
York). Aliquots of LPS stocks (200 d) were stored at —20°C,
and when thawed for use were sonicated for 15 seconds using a
microsonicator (Microson, Heat Systems-Ultrasonics). LPS
working dilutions were prepared in 10 mrvt Flepes saline formu-
lated using 1 M Hepes stock (Gibco Laboratories, Grand Island,
New York) and sterile, non-pyrogenic saline.
Culture of human mesangial cells
Human giomeruli were isolated from surgical specimen of
kidneys by the method described by Striker et al [23]. The
separated cortex was sliced and forced through a graded series
of stainless steel meshes, and isolated uncapsulated glotneruli
were recovered. MC were obtained from collagenase treated
isolated glomeruli in order to remove the epithelial cell compo-
nent [231. Washed glomerular remnants were plated at a density
of about 300 glomeruli/cm2 in Dulbecco's modified Eagle's
Medium and 20% fetal calf serum tested for endotoxin level less
than 0.1 nglml (Sigma Chimica, Milano, Italy), 50 U/mI of
penicillin and 50 jsg/ml of streptomycin; culture flasks were kept
in a 95% air, 5% CO2 environment at 37°C. After three weeks in
primary culture, MC were harvested with 0.05% trypsin, 0.02%
ethylene-diamine-tetracetate (EDTA). Subcultures were grown
in the same medium. The MC used were characterized by the
following criteria [24]: (a) morphologic appearance of stellate
cells growing in interwoven bundles; (b) uniform fluorescence
with F-PHD specific for f-actin; (c) immunofluorescence stain-
ing for smooth muscle-type myosin; (d) immunofluorescence
staining of extracellular matrix for type IV collagen and fi-
bronectin using monospecific antisera; and (e) negative immu-
nofluorescence staining for HLA-DR and leukocyte common
antigen (CD-45) and human factor VIII antigens. In parallel
experiments, cell viability was monitored by Trypan blue and
ranged between 88% and 95%.
Experimental protocols
For PAF generation, MC were grown to confluence in
six-well plates (Costar, Cambridge, Massachusetts, USA),
washed three times with Tris-buffered Tyrode (2.6 mrvi KCI, 1
mM MgCl2, 137 m'vi NaC1, 6 mrwi CaC12, 0.1% glucose, 1 mM
Tris, pH 7.4) and equilibrated for 15 minutes in Tris-buffered
Tyrode containing 0.25% delipidized BSA (fraction V) as pre-
viously described [14].
106 MC were incubated at 37°C for the indicated time with
different stimuli: 0.1 to 20 g/ml of porins or polymyxin
B-treated porins or 10 g/m1 LPS. In selected experiments, MC
(106) were preincubated with 1 ILM PBDB in the absence or
presence of 100 ILM lyso-PAF, or with 100 sM lyso-PAF alone,
for 30 minutes at 37°C and then treated with porins or with LPS.
After incubation of MC with porins or LPS, the supernatants
were removed and cells adherent to plastic dishes were washed
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in TTBSA and scraped. Each individual experiment was per-
formed in triplicate. In some experiments, MC were preincu-
bated for 30 minutes with 30 Ci Ij3HI-acetyl CoA or with 2.5
jtCi [methyl-3H]-choline. The supernatants and the cell pellets
were extracted according to Bligh and Dyer [25]. PAF was
quantitated after extraction and purification by thin layer chro-
matography (TLC) and high pressure liquid chromatography
(HPLC) by aggregation of washed rabbit platelets as previously
reported [141. In studies with labeled precursors of PAF, 0.5 cm
sections of TLC plates were scraped and counted. The biolog-
ically-active material extracted from cells and supernatants in
different experiments was characterized by comparison of
physico-chemical and biological characteristics with those of
synthetic PAF as previously described [141. In addition, the
chemical identity with the synthetic PAF (l-0-exadecyl-2-
acetyl-sn-glyceryl-3-phosphorylcholine) evaluated by a newly
developed technique based on high pressure liquid chromatog-
raphy-tandem mass spectrometry (HPLC-MS/MS) 1261. An API
III (Perkin Elmer SCIEX) mass spectrometer with an ionspray
articulated source, interfaced to a syringe pump HPLC (Ap-
plied Biosystems 140A) was used. Briefly each sample purified
by TLC was resuspended in 60 pJ of acetonitrile/water (90/10
vollvol) with 0.1% trifluoracetic acid (TFA). Fifty microliters of
sample were injected in HPLC on a reverse phase butyl wide
pore column (Hypersil WP-Butyl 100 x 1 mm Shandon) using a
mobile phase gradient composed by (A) methanol with 0.1%
TFA and (B) water with 0.1% TFA. The concentration of A was
increased from 30% to 80% in 20 minutes, with a linear gradient,
followed by an isocratic elution at 80% of A for 15 minutes at a
flow rate of 50 d/min.
Mass spectrometry analysis were performed under MS/MS
conditions. Daughter ions, in the range of 40 to 560 m/z, were
acquired in positive mode from parents of 524 m/z, that corre-
spond to the protonated molecular ion of C16-PAF. Fragmen-
tation was obtained by collision with argon at a collision gas
thickness of 2.5 x 1012 atoms/cm and at an impact energy of 70
eV. Standard C16-PAF was purified and analyzed with the same
technique.
The release of cytosolic lactate dehydrogenase activity
(LDH) was determined by a spectrometric method. LDH
release was expressed as the percentage of the total cellular
content which was determined by treating MC with 0.01%
Triton X- 100 for one hour at room temperature.
The role of extracellular Ca2 in porin-induced PAF synthe-
sis was evaluated on MC incubated in a balanced salt solution
(SS:0.159 M NaC1, 6.0 mM KC1, 0.8 mM MgSO4, 11.1 mM
glucose, 0.25% BSA, pH 7.4) in the absence or in the presence
of variuos concentrations of CaCl2 as described by Ludwig et al
[27]. In some experiments EDTA (ethylenediaminetetraacetic
acid) or EGTA (ethylene glycol bis[beta-amminoethylether]-
N,N'-tetraacetic acid) was added (final concentration, 10 mM)
to MC incubated in Ca2 containing Tyrode's buffer 10 minutes
prior to porin addition. The extracellular Ca2 uptake by
porin-stimulated MC was evaluated using 45Ca [28]. A total of
106 cells incubated in the balanced salt solution without CaCl2
and containing 0.2 m EGTA were challenged with porins. The
reaction was started by adding 2 mrvi CaC12, 0.5 rCi 45Ca, and
porins. Termination was achieved by adding 2.5 mrs EGTA and
5 1M ruthenium red (final concentration) on ice to remove cell
surface-bound calcium. After washing, the cell layer was solu-
bilized with 0.5 ml formic acid, and the radioactivity was
counted in the presence of 4 ml Instagel. Correction for
entrapment was made by using [3H]inulin (1 Ci/106 MC; 0.014
0.002 of [3H]inulin remained associated with stimulated and
unstimulated MC).
Enzymatic assays
For the measurement of acetyltransferase activity, cell ex-
tract preparation and the enzyme assay were previously de-
scribed [14]. Acetyltransferase activity was expressed as
nmoles of acetyl-CoA incorporated into lyso-PAF molecule per
minute of incubation and mg of protein in the lysate. The
release of ['4Cjarachidonic acid from cellular lipids, mainly
phospholipids, was measured by a modification [14] of the
method described by Hirata et al [291. The release was evalu-
ated after challenge with different stimuli at 37°C as described
for the release of PAF.
Statistical analysis
Data within different experimental groups were analyzed by
one-way analysis of variance (ANOVA) with Dunnett's or
Newman-Keuls multiple comparison test where appropriate.
Values are given as mean 1 SD. Values of P < 0.05 were
considered statistically significant.
Results
The experiments shown in Figure 1 established that human
MC synthesize PAF in response to porins. Porin-stimulated MC
produced PAF in amounts comparable to that obtained after
stimulation with TNF or LPS from S. typhimurium and —50%
of the amount produced after stimulation with LPS from E. coli
(0111 :B4) for three hours. PAF synthesized after stimulation
with porins as well as TNF remained mainly associated with
cells. Stimulation with LPS from E. coli also induced the
release in the supernatant of about 20% of the total amount of
PAF synthesized (Fig. 1). As shown in Figure 2, maximal PAF
synthesis occurred 20 minutes after addition of porins and
rapidly decreased thereafter being completely exhausted within
60 minutes. The synthesis of PAF induced by porins was more
rapid and less sustained than that induced by TNF which
peaked at 60 minutes. LPS induced a biphasic synthesis of PAF
with an early transient peak at 10 minutes and a delayed and
sustained peak between three to six hours. Pretreatment of
porins or TNF with polymyxin B did not impair the synthesis of
PAF (Table 1). In contrast, pretreatment of LPS with poly-
myxin B abrogated both the early transient and the delayed
sustained synthesis of PAF. Treatment of MC with cyclohex-
imide, an inhibitor of protein synthesis, prevented the delayed
and sustained synthesis of PAF induced by LPS, but not the
early transient peak of PAF induced by LPS. Cycloheximide
did not affected PAF synthesis induced by porins and TNF.
Anti-TNF antibodies abrogated the sustained synthesis of PAF
induced by LPS, but not the early and transient peak. In
contrast, anti-TNF antibodies were completely ineffective on
PAF synthesis induced by porins. The synthesis of PAF by MC
in response to different doses of porins was also measured (Fig.
3). PAF was extracted from cells and supernatant 20 minutes
after porin addition. PAF synthesis was detectable with 5 g/ml
of porins and was maximal with 10 g!ml. The viability of MC
after treatment with the concentrations of agents used was
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Fig. 1. Synthesis and release of PAF by 106
human MC treated with 10 sg/ml of porins
(20 mm) or with 10 g/ml of LPS from S.
typhimurium orE, coil (0111:B4; 3 hr) or with
10 nglml TNF (1 hr) or by control MC
incubated at 3TC for the same period of time
without any addition (None). Symbols are:
(blank columns); supernatant PAF (shaded
columns) cell-associated PAF. In this figure,
PAF concentration is referred to I ml of
supernatant and to the corresponding cell
aliquot to allow comparison of the amount of
PAF released with that remaining cell-
associated. Vertical bars indicate the standard
deviation of the mean of three different
experiments performed in duplicate. ANOVA
- ________ — with Dunnett's multiple comparison test was
performed between unstimulated cells (None)
and cells treated with different stimuli (* P <
0.05).
always greater than 90% and the release of LDH was <1%. A
significant reduction of cell viability was observed for concen-
trations greater than 50 g/ml and after 1 hour of treatment.
Characterization of PAF synthetized by MC
PAF was assayed after purification from cell and medium as
described in the Methods section, and it had biological and
physico-chemical characteristics identical to those of synthetic
PAF. It induced platelet aggregation in an ADP- and arachi-
donic acid-independent way, which was specifically inhibited
by the PAF receptor antagonists SDZ 63675, WEB 2170 and
CV3988. PAF activity was destroyed after base-catalyzed
methanolysis (0 to 2% residual activity) or treatment with
phospholipase A2, (0 to 5% residual activity), indicating the
presence of an ester linkage at sn-2 [30—321. Treatment with
phospholipase Al did not inhibit PAF activity, suggesting the
presence of an ether bond at sn-i [31]. PAF activity was
resistant to treatment with acids or weak bases [30]. After
base-catalyzed methanolysis or digestion with phospholipase
A2, treatment with acetic anhydride restored 80 to 90% of the
biologic activity. The PAF obtained from MC had the same Rf
(0.21) in TLC as synthetic PAF and migrated between lyso-PC
(Rf = 0.11) and sphingomyelin (RF = 0.29) using as solvent
chloroform/methanol/water (65:35:6), and the same Rt (20 mm)
of synthetic PAF (pPorasil column) developed with chloroform!
methanol/water (60:55:5). No PAF activity was detected in any
other TLC or HPLC fraction. The MS/MS spectra obtained
from porin- or LPS-stimulated MC samples at the retention time
characteristic for C-16 PAF (29,9 to 30,2 mm) exhibited a
fragmentation pattern characterized by molecular ion (m!z 523)
and a fragment corresponding to phosphocholine (mlz 183).
Figure 4 shows typical spectra of porin (A) or LPS (B) stimu-
lated MC sample containing 2.5 ng/ml and 3.4 ng/mI, respec-
tively of PAF-like bioactivity. An identical spectrum was ob-
tained with synthetic C-16 PAF submitted to the same
extraction and purification procedures of the samples (Fig. 4C).
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Fig. 2. Time course of total PAF synthesis by 106 human MC stimu-
lated: (A) with 10 jig/mi of porins (), (B) with 10 jig/mI of LPS from E.
co/i (A), or (C) with lOng/mi of TNF (•). Unstimulated cells were used
as control (•). Data are mean I SD of three experiments.
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Table 1. Synthesis of cell-associated PAF by human MC stimulated with porins, LPS or TNF in presence or absence of different additions
Additions
Stimulation
with porins
Stimulation with LPS Stimulation
with TNF10 mm 3 hr
None 2.65 0.3 4.10 0.2 5.06 0.1 3.40 0.2
Polymyxin B 2.54 0.4 0.20 0.la 0.20 o.la 3.32 0.3
Cycloheximide 2.68 0.2 3.85 0.3 0.20 0.2° 3.21 0.2
Anti-TNF antibodies 2.48 0.3 4.02 0.2 0.30 0.2° 0.2 0.2
A total of 106 human MC were incubated with 10 j.g/ml porins for 20 minutes or 10 g/ml LPS from E. co/i 0 111 :B4 for 10 minutes or 3 hours
or with 10 ng/ml TNF for 1 hour or with the same stimuli pretreated with 5 /Lg/ml polymyxin B as described in the Methods section. When indicated,
MC were stimulated in the presence of 0.1 mg/ml cycloheximide or 2 g/ml of anti-TNF antibodies. Values are expressed as mean I SD of four
different experiments. ANOVA with Dunnett's multiple comparison test was performed between control MC stimulated with porins, LPS or TNF
in the absence of any addition (None) and experimental groups.
a < 0.05
Porins, g/ml
Fig. 3. Dose response of PAF synthesis and release by human MC
stimulated for 20 minutes with porins. The cell-associated PAF (U) and
that released into the supernatant (A) by 1 x 106 cells treated with
different concentrations of porins are shown. Data are mean 1 SD of
three experiments.
Precursors and enzymes involved in PAF synthesis
Evidence that PAF was newly synthesized by MC treated
with porins or LPS was obtained by following the incorporation
of radioactive precursors. TLC analysis of lipid fractions ex-
tracted 20 minutes after addition of porins from MC preincu-
bated with [3H].acetyl-CoA showed one main peak of radioac-
tivity that comigrated with synthetic PAF (Fig. 5). This peak
was absent in the lipid fractions extracted from untreated MC.
Another set of experiments showed that exogenous 2-lyso-PAF
may serve as substrate for porin-induced PAF synthesis. TLC
analysis of the lipid fraction of MC preincubated with [3H12-
lyso-PAF plus 0.1 m unlabeled acetyl-CoA and then treated
with porins for 20 minutes showed three peaks of radioactivity
(Fig. 5). The first peak comigrated with 2-lyso-PAF, the second
peak with PAF, and the third peak with L-2-phosphatidylcho-
line (PC). In contrast, preincubation of MC with [methyl-3H]-
choline did not result in its incorporation in PAF molecules
synthesized either after stimulation with porins or with LPS
(data not shown). These results indicate that in MC the synthe-
sis of PAF induced by porins and LPS occurs via the remodel-
ing pathway rather than the de novo pathway, as previously
observed for TNF and phagocytosis. The activation of PLA2 is
the first step involved in PAF biosynthesis via the remodeling
pathway. As shown in Table 2, MC released ['4C1-arachidonic
acid after stimulation with porins in amounts comparable to
those observed after stimulation with LPS fromE. coliOlll:B4.
The basal level of [14C1-arachidonic acid released by control
cells was 0.48% of the label incorporated during preincubation.
After stimulation, MC released 3.5 to 4.6% of the total label
incorporated. PBDB, an inhibitor of PLA2 [331, markedly
reduced the release of [14C]-arachidonic acid as well as the
synthesis of PAF by porin- or LPS-stimulated MC (Table 2).
The inhibition of PLA2 by PBDB possibly prevented the
mobilization of 2-lyso-PAF, the substrate for the acetyl CoA:
2-lyso-PAF acetyltransferase. The second step involved in PAF
synthesis by the remodeling pathway is, in fact, the acetylation
of 2-lyso-PAF generated from membrane 1-0-alkyl-2-acyl-sn-
glyceryl-3-phosphorylcholine by PLA2. Indeed, the addition of
2-lyso-PAF to MC pretreated with PBDB restored the synthesis
of PAF induced by porins or LPS (Table 2). The activity of
acetyl CoA:2-lyso-PAF acetyltransferase was studied in paral-
lel with the synthesis of PAP. In unstimulated MC, basal
activity was 0.4 0.1 nmol/min/mg protein. This enzymatic
activity increased about seven- to ninefold during the synthesis
of PAF after stimulation with porins or LPS. The activation of
this enzyme paralleled the synthesis of PAF (Table 2) for both
porin and LPS MC stimulation.
Role of extracellular calcium in porin-induced PAF synthesis
In experiments designed to evaluate the role of extracellular
divalent cations on the synthesis of PAF, 10 mM EDTA or
EGTA was added to MC 10 minutes before stimulation with
porins (10 ig/ml) at 37°C for 20 minutes. The chelation of
extracellular divalent cations inhibited the synthesis of PAF
(control porin-stimulated cells: 2.65 0.3 ng/ml; EDTA-treated
cells: 0.10 0.1 ng/ml; EGTA-treated cells: 0.2 0.1 ng/ml).
The addition of trifluoroperazine (10 fLM), a drug that binds to
Ca2-calmodulin complex blocking its action on target enzymes
[34], five minutes before stimulation with porins also inhibited
the production of PAP (0.30 0.2 ng/ml).
Figure 6 shows the dose-response effect of extracellular Ca2
on PAP synthesis by MC incubated in calcium-free balanced
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Fig. 4. Spectra of the daughter ions from
parents with m/z 524 of a representative
sample of lOo MC treated with 10 jig/mI of
porins for 20 minutes (A) or with 10 jig/mi of
LPS from E. coli for three hours (B) and of
synthetic C16-PAF used as standard (C). In
the insert, the reconstructed chromatograms
of the daughter ions with m/s 183 from
parents of m/z 524 of the corresponding
samples are shown. The fragmentation spectra
are identical in A, B and C. Only one peak
can be observed in each chromatogram with
superimposable retention time.
salt solution (Methods). The different concentrations of Ca2
were added to MC 10 minutes before stimulation with porins.
PAF synthesis, detected as cell-associated PAF only, started at
concentrations of 0.01 mst Ca2. As shown in the experiments
with 45Ca2, porins rapidly increased the passage of from
the extracellular to the intracellular compartment. This effect
was sustained up to 30 minutes after porin addition (Fig. 7).
Discussion
The glomerular MC, a type of modified smooth muscle cell
that contracts in response to a number of mediators, may be
implicated in the endotoxin-induced acute hemodynamic renal
insufficiency characterized by a greater reduction in glomerular
filtration than in renal plasma flow [35]. MC react not only to
vasoactive agents, but also to a variety of inflammatory medi-
ators, including cytokines, eicosanoids, and PAF [36]. Gram-
negative sepsis causes exaggerated synthesis and release of a
number of mediators which may contribute to the pathogenesis
of acute renal failure and shock. The relative pathogenetic
importance of the biological action of components of the cell
wall of gram-negative bacteria and of mediators produced by
the host, such as IL-l and TNF, remains unknown.
TNF, in particular, is considered the main mediator of
endotoxin-induced inflammation and shock [37]. This cytokine
stimulates macrophages, PMN and vascular endothelial cells to
produce and release PAF [16]. In addition, it was recently
shown that cultured rat MC stimulated with LPS [9] and human
MC stimulated with TNF synthesized PAF [141. Since PAF,
which contracts MC [7], may function as an autacoid that acts
near its site of production, one may postulate that PAF,
synthesized within the gfomerulus produces renal functional
alterations in endotoxic/septic shock. Indeed, PAF is produced
during endotoxic shock and experimental sepsis by gram-
negative bacteria [2—4, 38]. PAF infusion in experimental ani-
mals produces hypotension, decrease in cardiac output, hypo-
volemic shock [391, and mimics the renal hemodynamic effects
of endotoxin [35]. PAF receptor antagonists inhibit and reverse
endotoxin-induced hypotension in rats and significantly reduce
mortality [2, 3]. In addition, PAF-receptor blockade prevents
the endotoxin-induced acute hemodynamic renal insufficiency
[35].
In endotoxic/septic shock, the synthesis of PAF may be
triggered either directly by biologically-active bacterial compo-
nents or toxins or by cytokines produced by the host. The LPS,
indeed, directly stimulates monocytes/macrophages and primes
PMN to synthesize PAF [40]. Beside LPS, the outer membrane
layer of gram-negative bacteria cell wall particularly contains
hydrophobic proteins [41] that are called porins because they
form trans-membrane channels for passive diffusion of solutes
across the outer membrane [17]. Porins that in the membrane
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Fig. 5. Representative TLC analysis of PAF synthetized by human MC
stimulated for 20 minutes with 10 sg/ml of porins after 10 minutes
preincubation with 15 Ci/ml [3H]-acetyl-CoA (A) or with 0.1 mM
unlabeled acetyl-CoA and 2 p.Ci/ml [3H]-lyso-PAF (B). The lipids
extracted from cells and supernatants were analyzed by TLC using as
solvent chloroform/methanol/acetic acid/water (50:25:8:4, vol/vol). The
plates were divided in 0.5 cm sections and counted as described in the
Methods section. The pattern obtained with porin-stimulated MC (line)
and control unstimulated MC (dotted line) is shown. Three experiments
were performed with similar results on cell-associated and supernatant
lipids.
are in trimeric form [421 may be released either during cell
growth or during bacteriolysis [43]. Given their resistance to
proteolysis [441, they are not degraded and may insert in the
plasma-membrane of the cells of the host organism with marked
changes in lipidic and proteic phase relations [18]. Depending
on the dose, porins may be cytotoxic for target cells or may
interfere with cell functions [45]. Porins binding to human PMN
were shown to reduce phagocytosis and intracellular killing of
gram-negative bacteria [45] and to decrease the oxidative burst
and the cell hydrophobicity causing alterations in cell morphol-
ogy [18]. Moreover, subtoxic concentrations of porins act both
as chemotaxins and chemotaxinogens on PMN [18]. Porins,
once injected in the rat paw, were shown to induce an inflam-
matory reaction which was independent from the activation of
complement [461, despite their ability to activate the comple-
ment system in vitro [47].
In the present study, we demonstrate that porins at non-toxic
concentrations stimulate a transient rapid synthesis of PAF
from human MC. This effect of porins does not depend on LPS
contamination or TNF production. In fact, the treatment of
porins with polymyxin B that abrogates the biological activity
of LPS and incubation of MC with anti-TNF antibodies did not
affect the synthesis of PAF induced by porins. In addition, the
kinetic action of PAF synthesis induced by LPS differs from
that of porins. After LPS stimulation a biphasic response was
observed with a first transient pick of PAF synthesis at 10
minutes and a second delayed and sustained pick between three
and 6 hours. Protein synthesis blockade by cycloheximide did
not abrogate either PAF synthesis induced by porins or by
TNF, or the early transient synthesis of PAF induced by LPS.
In contrast, the delayed and sustained synthesis of PAF ob-
served after incubation with LPS at three to six hours was
dependent on protein synthesis and was inhibited by anti-TNF
antibodies, suggesting the dependency of PAF synthesis on the
production of TNF.
Therefore, human MC may synthesize PAF with a dual
mechanism, a direct mechanism that triggers a rapid but tran-
sient synthesis of PAF also described in rat MC [9], and a
cytokine-dependent mechanism that seems related to the LPS
stimulated synthesis of TNF. The experiments with labeled
precursors indicate that MC synthesized PAF both in response
to porins and LPS via the remodeling pathway, as previously
observed for stimulation with IL- 1, TNF and phagocytosis [14].
The remodeling pathway involves the activation of two enzy-
matic steps, including the hydrolysis of 2-lyso-PAF by PLA2
and its acetylatiori at position-2, by a specific acetyltransferase.
The first step requires Ca2, is inhibited by PBDB and is
associated with the mobilization of arachidonic acid. The sec-
ond step is detected by the incorporation of labeled acetate into
PAF synthesized by cells preincubated with labeled acetyl-
CoA.
The PLA2 activity in intact cells was estimated by measuring
the release of label from MC preincubated with ['4C]arachi-
donic acid [14, 29]. Both porins and LPS induced the release of
[14C]-arachidonic acid. The release of arachidonic acid from
cellular phospholipids may also depend on the phospholipase-
C/diacylglycerol lipase pathways. Since 1,2 [3H1-arachidonoyl-
diacylglycerol formation was not measured in the present
study, a concomitant activation of this pathway cannot be
excluded. However, the inhibitory effect of PBDB that prevents
PLA2 activity [331 suggests the prevalence of a direct deacyla-
tion of phospholipids by PLA2. The inhibition of PLA2 by
PBDB also blocks the synthesis of PAP by preventing the
mobilization of 2-lyso-PAF, the substrate for PAP-specific
acetyl-CoA:2-lyso-PAF acetyltransferase. Indeed, the addition
of exogenous 2-lyso-PAF restores the synthesis of PAF in
porin- as well as LPS-stimulated MC, The activation of the
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Table 2. Release of '4C-arachidonic acid, acetyl-CoA:2-lyso-PAF acetyltransferase activity and PAF synthesis by human MC stimulated by
porins or LPS
Acetyl-transferase
Additions
'4C-arachidonic
acid released
c.p.m.
activity
nmollminlmg of
protein
PAF synthesis
ng/ml
None 532 99 0.40 0.1 0.10 0.1
Porins 2880 44° 3.17 0.4° 2.65 o.3
LPS 4958 26° 3.93 0.2" 5.06 o.4
Porins plus PBDB 920 60" 3.41 0.3 0.30 0.2"
LPS plus PBDB 1250 32'-' 3.52 0.4 0.90 0.1"
Porins plus PBDB plus 914 132C ND 2.46 0.3"
Lyso-PAF
LPS plus PBDB plus 1134 93° ND 4.90 01d
Lyso-PAF
A total of 106 MC were incubated at 37°C with 10 g/ml porins for 20 minutes or 10 rg/m1 LPS for 3 hours with or without addition of PBDB
(1 LM) or PBDB (1 /LM) plus 2-lyso-PAF (10 ,,LM). The release of l'4C]-arachidonic acid was performed as described by Hirata et al [291. The
acetyl-transferase activity and the synthesis of PAF was measured as described in the Methods section. ANOVA with Newman-Keuls multiple
comparison test was performed between unstimulated cells and cells stimulated with porins or LPS in the absence of additions ("P < 0.05);
between porin- or LPS-treated cells in the absence of additions and after addition of PBDB (" P < 0.05) or PBDB plus 2-lyso-PAF (° P < 0.05)
and between porin- or LPS-treated cells in presence of PBDB and after addition of PBDB plus 2-lyso-PAF (' P < 0.05).
0 0.001 0.01 0.1 1 1.4
[Ca2j, m,'vi
Fig. 6. Effect of extracellular Ca2 concentrations on PAF synthesis
by 106 human MC incubated in calcium-free balanced salt solution
(Methods) and stimulated for 20 minutes with 10 gIml porins (A) or
unstimulated (U). Calcium in the indicated concentrations was added 10
minutes before stimulation with porins. Data are mean 1 SD of three
experiments.
remodeling pathway is also indicated by the incorporation of
the label in PAF synthesized after preincubation with [3H]-
acetyl-CoA but not with [methyl-3H]-choline. Porins and LPS,
in addition, increase the activity of acetyl CoA:2-lyso-PAF
acetyltransferase by about seven- to ninefold. We focused on
the study of the mechanism of porin-induced PAF synthesis by
evaluating the role of influx of extracellular Ca2t Previous
studies established that mobilization of intracellular Ca2" plays
only a minor role in the induction of PAF synthesis, whereas
the activation of enzymes involved in the remodeling pathway
mainly requires an influx of extracellular Ca2 [271. The studies
on 45Ca2 influx in porin-stimulated MC indicate that porins
determine a sustained increase in membrane permeability to
Ca2. This observation may be explained by the binding of
porins to MC membranes with formation of trans-membrane
channels for passive diffusion of small solutes [18]. Since the
concentration of free Ca2 in the cytosol is about l0 times
lower then that of extracellular fluid, a large gradient tends to
drive Ca2 into cytosol across porin—formed trans-membrane
channels. The experiments with trifluoperazine, an inhibitor of
Ca2 + -calmodulin complexes, suggest that calmodulin regulates
Ca2 dependent activation of enzymes involved in the synthesis
of PAF by porin-stimulated MC, as observed for PMN stimu-
lated with calcium ionophore [34]. Both the PLA2 and the
acetyltransferase involved in PAF synthesis are calcium depen-
dent enzymes [48]. The PLA2 involved in the synthesis of PAF
seems to cleave selectively arachidonic acid and translocate to
the membranes in a Ca2'--dependent fashion [491. Recently
described was a cytosolic PLA2 that contains a 45 amino acid
region with homology to protein kinase C, synaptic vesicle
protein p65, GTPase activating protein, and phospholipase C,
suggesting a Ca2-dependent phospholipid-binding motif as
mechanism for the second messenger Ca2 to translocate and
activate cytosolic proteins [50]. The activation of PAF-specific
acetyltransferase besides Ca2 seems to require phosphoryla-
tion [511.
The present demonstration, that besides LPS and cytokines
other bacterial components directly promote the synthesis of
PAF by MC, suggests that a number of stimuli may contribute,
either independently or synergistically, to the stimulation of
MC in gram-negative bacterial infections. The synthesis of PAF
by MC may be relevant for the pathogenesis of acute renal
injury related to gram-negative bacterial infections. However,
the exact relationship between MC-derived PAF and other
mediators, such as eicosanoids and cytokines, appears worthy
of further study.
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